Navigation Links
Cord Blood America Reports Six Month Financial Results
Date:8/20/2008

LOS ANGELES, Aug. 20 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, today reported that revenues for the first six months of 2008, ended June 30, totaled $2.4 million.

Revenues were down from the same period in 2007 because of a $1.5 million decrease in revenues at Rainmakers International, the Company's advertising subsidiary. Rainmakers switched business strategies in late 2007, focusing on low cost, high volume, annuity based advertising rather than relying on a few large contracts. Benefits from the change in business plan are slowly being realized.

Gross profit as a percent of revenues increased over the period from 35 to 55 percent, due to a significantly higher proportion of revenue deriving from the Company's primary umbilical cord blood storage business. "I would also urge shareholders to focus on the decrease in the loss from operations, which we have cut in half. I believe this shows our focus and ability to structure a business entity that stands strong on its own," said Matthew Schissler, CEO, Cord Blood America.

"We are dedicated to growing our umbilical cord blood storage business through strategic organic growth and accretive acquisition strategies," Mr. Schissler said. "We remain confident about the future of our Company and its business strategies."

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powe
'/>"/>

SOURCE Cord Blood America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Poor Sleep Linked to High Blood Pressure in Teens
2. Air Pollution Can Damage Heart, Blood Vessels, Too
3. White blood cell uses DNA catapult to fight infection
4. Tiny molecule helps control blood-vessel development, UT Southwestern researchers find
5. Gioia & New York Blood Center Call for City Aid in Expansion of Mobile Blood Donor Coach Program
6. Gladstone scientists identify single microRNA that controls blood vessel development
7. Too Much Salt Boosts Blood Pressure
8. UCLA and biotech company develop first blood test to measure key hormone that regulates iron
9. Blood Sugar Test May Also Aid Diabetes Detection
10. Blood-Thinner Plavix Works Harder in Smokers
11. Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 2Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 3Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 4Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 5Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Confusion Over Homeopathic Medicines in Alexa Ray Joel's Hospitalization Clarified by the American Association of Homeopathic Pharmacists (AAHP) 2Former UN Human Rights Rapporteur Offers 7 Points of Action on Iran to the UN Secretary General 54034 1Former UN Human Rights Rapporteur Offers 7 Points of Action on Iran to the UN Secretary General 54034 2PTC Therapeutics Announces Achievement of Major Milestone in Schering Plough Hepatitis C Collaboration 13470 1PTC Therapeutics Announces Achievement of Major Milestone in Schering Plough Hepatitis C Collaboration 13470 2PTC Therapeutics Announces Achievement of Major Milestone in Schering Plough Hepatitis C Collaboration 13470 3China Biotics Inc Receives High Technology Enterprise Certification to Qualify for Preferential Income Tax Rate 13468 1China Biotics Inc Receives High Technology Enterprise Certification to Qualify for Preferential Income Tax Rate 13468 2China Biotics Inc Receives High Technology Enterprise Certification to Qualify for Preferential Income Tax Rate 13468 3